Botulinum toxin A as a treatment modality for acute acquired comitant esotropia – An Indian perspective
Purpose: To analyze the outcomes of botulinum toxin A injection in acute acquired comitant esotropia (AACE). Methods: This is a retrospective study that included cases diagnosed as AACE between January 2022 and February 2023. Patients who were treated with Botox and completed a minimum 3 months foll...
Saved in:
Main Authors: | Akshay Badakere, Vibha Badrinath, Hennaav Kaur Dhillon, Abinaya Valliappan, Viswanathan Natarajan, Sumita Agarkar |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2025-02-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/IJO.IJO_2198_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Botulinum toxin-A in acute acquired comitant esotropia during COVID pandemic in children and young adolescents
by: Neelam Pawar, et al.
Published: (2025-02-01) -
The Effect of Different Doses of Botulinum Toxin on Masseter Muscle in Patients with Bruxism.
by: Kawa F. Dizaye, et al.
Published: (2022-02-01) -
A systematic review and meta-analysis of neuromuscular electrical stimulation post-botulinum toxin injection in children with cerebral palsy
by: Fu-An Yang, et al.
Published: (2025-02-01) -
Case Report: Combination of focal vibration therapy and botulinum toxin injections to treat equinus gait in a child with unilateral spastic cerebral palsy
by: Christophe Boulay, et al.
Published: (2025-02-01) -
The occupational roles of hospitalized people due to Acquired Immune Deficiency Syndrome
by: Natália Augusto Nunes Gil, et al.
Published: (2014-04-01)